Patient-derived cancer models: Valuable platforms for anticancer drug testing by Sofia Genta, Bryan Coburn, David W. Cescon, Anna Spreafico

Get full text

Antibody-Drug Conjugates to Promote Immune Surveillance: Lessons Learned from Breast Cancer by Sabrina Nucera, Chiara Conti, Federica Martorana, Brooke Wilson, Sofia Genta

Get full text

TOP2A as marker of response to pegylated lyposomal doxorubicin (PLD) in epithelial ovarian cancers by Eleonora Ghisoni, Furio Maggiorotto, Fulvio Borella, Gloria Mittica, Sofia Genta, Gaia Giannone, Dionyssios Katsaros, Alberto Sciarrillo, Annamaria Ferrero, Ivana Sarotto, Jessica Erriquez, Maria Flavia Di Renzo, Massimo Aglietta, Giorgio Valabrega

Get full text

A predictive score for optimal cytoreduction at interval debulking surgery in epithelial ovarian cancer: a two- centers experience by Eleonora Ghisoni, Dionyssios Katsaros, Furio Maggiorotto, Massimo Aglietta, Marco Vaira, Michele De Simone, Gloria Mittica, Gaia Giannone, Manuela Robella, Sofia Genta, Fabiola Lucchino, Francesco Marocco, Fulvio Borella, Giorgio Valabrega, Riccardo Ponzone

Get full text

Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers by Gloria Mittica, Margherita Goia, Angela Gambino, Giulia Scotto, Mattia Fonte, Rebecca Senetta, Massimo Aglietta, Fulvio Borella, Anna Sapino, Dionyssios Katsaros, Furio Maggiorotto, Eleonora Ghisoni, Gaia Giannone, Valentina Tuninetti, Sofia Genta, Chiara Eusebi, Marina Momi, Paola Cassoni, Giorgio Valabrega

Get full text

Autoimmune PaneLs as PrEdictors of Toxicity in Patients TReated with Immune Checkpoint InhibiTors (ALERT) by Sofia Genta, Katherine Lajkosz, Noelle R. Yee, Pavlina Spiliopoulou, Alya Heirali, Aaron R. Hansen, Lillian L. Siu, Sam Saibil, Lee-Anne Stayner, Maryia Yanekina, Maxwell B. Sauder, Sareh Keshavarzi, Abdulazeez Salawu, Olga Vornicova, Marcus O. Butler, Philippe L. Bedard, Albiruni R. Abdul Razak, Robert Rottapel, Andrzej Chruscinski, Bryan Coburn, Anna Spreafico

Get full text

Increase in serum choline levels predicts for improved progression-free survival (PFS) in patients with advanced cancers receiving pembrolizumab by Wei Xu, Anna Spreafico, Stephanie Lheureux, Marcus O Butler, Aaron R Hansen, Eric Chen, Ben Wang, Philippe L Bedard, Albiruni Abdul Razak, Dave Cescon, Lillian L Siu, Tak W Mak, Geoffrey Alan Watson, Enrique Sanz-Garcia, Wen-Jiang Zhang, Zhihui Amy Liu, SY Cindy Yang, Shaofeng Liu, Shawn Kubli, Hal Berman, Thomas Pfister, Sofia Genta

Get full text